These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35105149)

  • 1. SARS-COV-2 PANDEMIC FROM THE OPHTHALMOLOGIST`S PERSPECTIVE. A REVIEW.
    Navarčík R; Popov I; Valašková J; Horkovičová K
    Cesk Slov Oftalmol; 2022; 78(5):217-332. PubMed ID: 35105149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ocular surface, coronaviruses and COVID-19.
    Willcox MD; Walsh K; Nichols JJ; Morgan PB; Jones LW
    Clin Exp Optom; 2020 Jul; 103(4):418-424. PubMed ID: 32406140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye.
    Al-Sharif E; Strianese D; AlMadhi NH; D'Aponte A; dell'Omo R; Di Benedetto R; Costagliola C
    Int Ophthalmol; 2021 Jan; 41(1):349-362. PubMed ID: 32880786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implication of ocular manifestation of COVID-19 for medical staff and patients - systematic review.
    Latalska M; Mackiewicz J
    Ann Agric Environ Med; 2020 Jun; 27(2):165-170. PubMed ID: 32588588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.
    Dockery DM; Rowe SG; Murphy MA; Krzystolik MG
    J Emerg Med; 2020 Jul; 59(1):137-140. PubMed ID: 32456959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.
    Seah I; Agrawal R
    Ocul Immunol Inflamm; 2020 Apr; 28(3):391-395. PubMed ID: 32175797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precaution and prevention of coronavirus disease 2019 infection in the eye.
    Chen MJ; Chang KJ; Hsu CC; Lin PY; Jui-Ling Liu C
    J Chin Med Assoc; 2020 Jul; 83(7):648-650. PubMed ID: 32332516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular symptoms in SARS-CoV-2 infection].
    Gregorczyk M; Roskal-Wałek J
    Pol Merkur Lekarski; 2022 Apr; 50(296):86-93. PubMed ID: 35436269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and the Eye: Ocular Manifestations, Treatment and Protection Measures.
    Yener AÜ
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1225-1233. PubMed ID: 34648417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COVID-19 Pandemic from an Ophthalmologist's Perspective.
    Bacherini D; Biagini I; Lenzetti C; Virgili G; Rizzo S; Giansanti F
    Trends Mol Med; 2020 Jun; 26(6):529-531. PubMed ID: 32470381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
    Wu P; Duan F; Luo C; Liu Q; Qu X; Liang L; Wu K
    JAMA Ophthalmol; 2020 May; 138(5):575-578. PubMed ID: 32232433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
    Davidson AM; Wysocki J; Batlle D
    Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical Practice.
    Torres-Costa S; Lima-Fontes M; Falcão-Reis F; Falcão M
    Acta Med Port; 2020 Sep; 33(9):593-600. PubMed ID: 32662416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Eye on COVID-19: A Meta-analysis of Positive Conjunctival Reverse Transcriptase-Polymerase Chain Reaction and SARS-CoV-2 Conjunctivitis Prevalence.
    Sopp NM; Sharda V
    Optom Vis Sci; 2021 May; 98(5):429-436. PubMed ID: 33973912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.